Return to homepagePandemic Pact

DISCOVERING BIOMARKERS TO DETECT COVID-19 PATIENTS AT HIGHER RISK OF HEART PROBLEMS [Funder: Ted Rogers Centre for Heart Research]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    Other Funders (Canada)

  • Principal Investigator

    Kate and Kathryn and Dinesh Hanneman and Howe and Thavendiranathan

  • Research Location

    Canada

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

As most COVID-19 patients survive, and cardiac injury is common during infection, there may be significant long-term consequences to the heart that must be explored. Today, we know little about the risk factors for cardiovascular events in COVID patients, any biomarkers to recognize heart issues early, or how such problems may manifest in survivors. This collaborative study seeks to find vascular and cardiac biomarkers that will identify patients at higher risk for short- and long-term adverse events, by characterizing COVID-19's impact on the heart. It will also explore the relationship between these biomarkers, how they can be tracked by echocardiography and MRI, and patient outcomes.